proteases inhibitors
Showing 4226 - 4234 of 4,234
HIV Trial in United States (Indinavir sulfate, Nelfinavir mesylate, Efavirenz)
Completed
- HIV Infections
- Indinavir sulfate
- +2 more
-
Beverly Hills, California
- +4 more
Jun 23, 2005
HIV Trial in Research Triangle Park (Amprenavir)
Completed
- HIV Infections
-
Research Triangle Park, North CarolinaGlaxo Wellcome Inc
Jun 23, 2005
HIV Trial in Puerto Rico, United States (Nelfinavir mesylate, Levocarnitine, Adefovir dipivoxil)
Completed
- HIV Infections
- Nelfinavir mesylate
- +6 more
-
Phoenix, Arizona
- +14 more
Jun 23, 2005
HIV Trial in United States (Abacavir sulfate, Amprenavir, Efavirenz)
Completed
- HIV Infections
- Abacavir sulfate
- +2 more
-
Berkeley, California
- +8 more
Jun 23, 2005
HIV and Cytomegalovirus (CMV) in HIV-Infected Patients
Completed
- Cytomegalovirus Infections
- HIV Infections
-
Birmingham, Alabama
- +35 more
Jun 23, 2005
HIV, Hyperlipidemia Trial in New York (Rosiglitazone)
Completed
- HIV Infections
- Hyperlipidemia
-
New York, New YorkDivision of Endocrinology
Jun 23, 2005
Heart Diseases Trial in Denver (pravastatin)
Unknown status
- Heart Diseases
-
Denver, Colorado4200 E. 9th Avenue, Box B133
Jun 23, 2005